Which laboratory tests should be ordered in a fasting morning sample to evaluate for polycystic ovary syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 10, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Laboratory Evaluation for PCOS

For PCOS evaluation, draw a fasting morning sample (ideally days 3-6 of the menstrual cycle or any time if amenorrheic) that includes: total and free testosterone, LH, FSH, TSH, prolactin, and 17-hydroxyprogesterone to exclude mimicking conditions. 1, 2

Core Hormone Panel

The essential laboratory workup requires measuring specific hormones to both diagnose PCOS and exclude other conditions that present similarly:

Primary Androgen Assessment

  • Total testosterone - Most laboratories should measure this, though assay quality varies significantly 1
  • Free testosterone - When measured by gold-standard assays (LC-MS/MS or equilibrium dialysis), this is the most useful indicator of PCOS 1, 3
  • SHBG - Allows calculation of Free Androgen Index (FAI = [Total testosterone/SHBG] × 100) if direct free testosterone unavailable 1, 3

Critical caveat: Immunoassays for testosterone are notoriously unreliable at the low concentrations seen in women. If your initial testosterone is normal but clinical suspicion remains high, recheck using a specialty laboratory with LC-MS/MS methodology 1, 4. The 2025 meta-analysis confirms that free testosterone measured by LC-MS/MS has superior diagnostic accuracy (AUC 0.90) compared to direct immunoassays (AUC 0.82) 3.

Gonadotropins

  • LH and FSH - Measure both to calculate LH/FSH ratio 1, 5
    • PCOS typically shows LH <15 IU/L, FSH <10 IU/L, with LH > FSH ratio 1
    • LH/FSH ratio >2:1 occurs in 55% of PCOS patients 6
    • This helps differentiate from ovarian insufficiency (where both are elevated >15 IU/L) and functional hypothalamic amenorrhea (where both are low <10 IU/L) 1

Mandatory Exclusion Tests

These three tests must be performed in all women being evaluated for PCOS 1, 2:

  • TSH (and free T4 if TSH abnormal) - Excludes thyroid dysfunction causing menstrual irregularity 1, 7, 2
  • Prolactin - Excludes hyperprolactinemia, which can present identically with amenorrhea and hirsutism 1, 7, 2
  • 17-hydroxyprogesterone (8 AM fasting) - Screens for nonclassic congenital adrenal hyperplasia, found in 1.5-6.8% of hyperandrogenic women 1, 2

Additional Androgens (Selective Use)

  • DHEA-S - Consider measuring to assess adrenal androgen contribution 1, 4

    • Particularly important if signs of virilization present
    • Levels >600 μg/dL suggest adrenal tumor 1
    • High-normal levels are common in PCOS, especially in normal-weight women 1
  • Androstenedione - Has lower diagnostic accuracy (AUC 0.80) than testosterone or FAI 3, so not essential for routine diagnosis

Metabolic Screening

While not required for diagnosis, metabolic assessment is critical given PCOS-associated risks 7, 2:

  • Fasting glucose and 2-hour oral glucose tolerance test (75g load) - ACOG recommends this for all PCOS patients due to increased diabetes risk 7
  • Fasting lipid panel - Screen for dyslipidemia (total cholesterol, LDL, HDL, triglycerides) 7
  • Fasting insulin - Some use glucose/insulin ratio <4.5 as insulin resistance indicator, though not standardized 8

Optional/Adjunctive Tests

  • AMH (anti-Müllerian hormone) - Often elevated in PCOS and can be helpful adjunct 1, but not required for diagnosis and has limited specificity in adolescents 9
  • Mid-luteal progesterone - If ovulatory status unclear; <6 nmol/L indicates anovulation 5

Timing and Practical Considerations

Optimal timing: Draw blood in early follicular phase (days 3-6 of cycle) in regularly cycling women, as reference ranges are standardized to this timeframe 4. In amenorrheic women, draw at any time but document this 1.

Morning collection: Testosterone and 17-OHP must be drawn in early morning (8 AM) due to diurnal variation 1, 4.

Assay familiarity: Know your local laboratory's reference ranges and assay methods - they vary significantly between facilities 1. If using immunoassays and results don't match clinical picture, send to specialty lab with mass spectrometry 1, 4.

Common Pitfalls to Avoid

  1. Don't rely solely on total testosterone from standard immunoassays - they lack sensitivity at female ranges 1, 3
  2. Don't skip the exclusion tests (TSH, prolactin, 17-OHP) - these conditions are treatable and have different management 2
  3. Don't check LH/FSH during mid-cycle - you may catch the ovulatory surge (high FSH/LH with estradiol >150 pg/mL) and misinterpret results 1
  4. Don't measure androgens post-ictally in epilepsy patients - prolactin will be falsely elevated 5

References

Guideline

functional hypothalamic amenorrhea: an endocrine society clinical practice guideline.

The Journal of clinical endocrinology and metabolism, 2017

Guideline

reproductive dysfunction in women with epilepsy: recommendations for evaluation and management.

Journal of Neurology, Neurosurgery and Psychiatry, 2002

Research

Polycystic ovary syndrome: clinical and laboratory evaluation.

Sao Paulo medical journal = Revista paulista de medicina, 1996

Guideline

american association of clinical endocrinologists medical guidelines for the clinical practice for the diagnosis and treatment of hyperandrogenic disorders.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologist, 2001

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.